Staphylococcus aureus (S. aureus) is a challenging human pathogen due to its ability to evade the 20 immune system and resist multidrug antibiotics. These evasive strategies lead to chronic and re-21 current infections. Many studies have documented that during chronic infections Myeloid Derived 22 Suppressor Cells (MDSCs) exert immunosuppressive mechanisms on T cells. A mathematical 23 model explains how the steady state of chronic infection can be disturbed and suggests therapeutic 24 strategies to clear the infection. Model-driven suggestions were tested experimentally and con-25 firmed complete clearance of S. aureus chronic infection. 26 Keywords 27 Myeloid Derived Suppressor Cells, MDSCs, Staphylococcus aureus, chronic infection, mathematical model, 28 therapy, cure, heat-killed cells 29
MDSCs T cells
Bacteria activate T cells as k b B(t), which proliferate as r t T 2 (t) and suppress bacteria as c b T (t)B(t). Once the bacterial infection becomes chronic, strong MDSC suppression on T cells takes place either locally as c T B(t)T (t) or systemically as Σ · T (t). (B) Initiation of the infection in a previously healthy host causes strong inflammation, which rapidly activates T cells. Infection was induced by setting the bacterial population equal to 5 × 10 7 cells on day 0 in Eq. (1). The oscillatory dynamics of bacteria (B) and activated T cells (T) in time are shown as numerical solutions of the ODE system (see Methods). (C) The interplay between bacteria and CD4 + T cells leads to a stable steady state. For changing initial numbers of bacteria in the range [10 5 , 6 × 10 7 ) on day 0, the system always terminates in the stable equilibrium, which physiologically corresponds to the chronic infection. (D) Infection was initiated as in (B) . The day of simulated clearance is shown for increasing values of Σ in the range [0, 0.2], physiologically representing MDSC accumulation in the lymphoid organs and incremental T cell suppression by MDSCs. For changing value of the parameter Σ in the range [0, 0.2], the ODE solver calculates the bacterial numbers. For bacterial numbers < 0.000001, the infection is considered cured (dashed line), else persisting (solid line). For resolved infections the corresponding day of clearance is shown, or set to zero for persisting (i.e. chronic) infections. The black star represents the scenario when MDSCs are absent and hence T-cell suppression does not exist (Σ = 0). The white star represents the critical value of Σ, when the infection becomes persistent. The values for the rest of the model parameters are as shown in Table 1 . Based on the eigenvalues of the system, the phase diagram was divided into stable state (black) and unstable state (green), which represent the physiological chronic infection and cure, respectively. The white star represents the average position of the infected host during a chronic staphylococcal infection, which was determined by the values of parameters k b and Σ as obtained from the fitting results (Table 1 ). The gray area (cloud) was created using the 95% confidence intervals of parameters k b and Σ as obtained from the fitting results (Table 1 ) and represents possible positions of the infected mice in the separatrix. (A) Given that the state of infected hosts is as illustrated, it is obvious that mere increase of T cell activation and recruitment parameter k b and/or decrease MDSC suppression on T cells Σ would shift the infected host into the green area of sterilizing immunity (black stars). (B) Increasing the cure regime (green) is achieved by utilizing counter-intuitive therapeutic ideas such as reduction of bacteria's killing rate via immune cells c b and/or increasing the proliferation rate of bacteria r b . Expansion of the cure area engulfs the infected host (white star), providing sterilizing immunity. (C) Increase of T-cell activation and recruitment parameter k b confers sterilizing immunity from a S. aureus chronic infection in silico. Re-stimulation of the immune system is induced by administering 10 8 HK cells on the 14th day post-infection for a perturbation window that lasts half day (see Methods). Infection was induced by setting the bacterial population equal to 5 × 10 7 cells on day 0 in Eq. (1).
Complete bacterial clerance after heat-killed bacteria perturbation treatment Sampling on the 37th day post-infection validated the model's predictions. All mice, which had received the 138 perturbation of HK S. aureus cells, achieved sterilizing immunity from S. aureus chronic infection ( Fig. 3B ). In 139 contrast, the majority of control mice, which had only received PBS instead of HK bacteria were still infected 140 with high bacterial burden ( Fig. 3B ).
141

Recovery of T cell function 142
Given the fact that progression of a S. aureus infection from acute to chronic renders T cells anergic 31 , our 143 next step was to check the proliferative response of spleen T cells. Our results indicated that spleen T cells 144 from treated mice were hyper-responsive to stimulation with anti-CD3 and anti-CD28 antibodies and actively 145 proliferated ( Fig. 3D ). However, T cells of infected control mice, which had received PBS instead of HK bacteria, 146 exhibited unresponsiveness to TCR re-stimulation ( Fig. 3D ).
147
Reduction of MDSCs after heat-killed bacteria perturbation 148 Interestingly, we found that the perturbation of the chronic system with HK bacteria did not only boost T cell 149 function, but also aided in MDSC abatement. CD11b + Ly6C + monocytes increased massively after the HK injection, whereas in case of HK S. pyogenes treatment, which cured half of the infected hosts, CD11b + Ly6G + granulocytes (neutrophils) increased massively 182 after the HK injection ( Fig. S5 ).
183
Reasoning for past unsuccessful applications of the treatment 184
Our model-driven protocol suggesting the HK dose, its administration day, and day of complete clearance has 185 been proven reliable and effective. Even though administration of killed cells as treatment for infections has been 186 used in the past, this kind of therapy has not been well established. This is due to lacking information regarding 187 the HK dose needed and day(s) of administration that could resolve the infection successfully. At the moment 188 all treatments involving inactivated bacteria have been based on vague experimental experience.
189
Here, we explain in silico why heat-or formalin-killed bacteria treatments used so far have not been success-190 ful in yielding clearance. We base our arguments on a previous study 32 , where scientists administered at least 191 19 formalin-killed bacteria injections with increased dose over the period of 3 months in human patients with 192 furunculosis.
193
In the study none of the chronically infected patients was reported to have attained sterilizing immunity, even -Suspension III: (0.5, 0.6, 0.7, 0.8, 0.9, 1) × 2.5 × 10 9 .
199
We assumed that the bacterial capacity in humans is 1000 times greater than the bacterial capacity in mice, 
206
The conventional administration of injections is based on the belief that repeated vaccination could work 207 more efficiently. Here, we employed in silico the analogous protocol that has been used in humans and showed 208 that repeated administration of injections with increasing dose cannot render eradication of the infective agent 209 ( Fig. 4, (A,B,C) ). We also explored the case where repeated injections of fixed dose are given. However, even 210 with high fixed doses the treatments still fail to eliminate the infection ( Fig. 4 , (D,E,F)). Our results explicitly 211 negate the current belief by showing that challenging the system repeatedly and in high frequency intervals does 212 not result in cure ( Fig. 4 ).
213
We also correlated the HK dose, number of injections and intervals [days] between injections for HK doses 214 from 10 6 to 10 7 (Fig. S6 ). Our in silico results suggested that the suspensions and intervals used in the study 215 with furunculosis patients 32 were fruitless attempts towards bacterial clearance, since the administered HK doses 216 in intervals of 3-5 days could not reactivate the hosts' immune systems in a sufficiently strong manner against 217 bacteria ( Fig. S6 ). We furthermore associated the HK dose, number of injections and intervals [days] between 218 injections for HK doses from 10 7 to 10 8 . Our results clearly indicated that the longer the intervals between 219 injections, the higher the HK doses required for cure and the lesser the probability for cure ( Fig. S7 ). 
242
Our model uses current knowledge in the field and refines it to foster complete clearance. All four suggested 243 perturbation strategies, even so different from each other, have a common factor: during a chronic infection they 244 initiate an acute inflammation, which instigates proinflammatory responses. Consequently, the immune system is impelled to action, which further leads to alleviation of the infection or, given the adequate strength of stimulation, to sterilizing immunity. Our experiments in vivo verified that HK injection initiates acute inflammation 247 during the chronic establishment of S. aureus infection, showing massive increase in amounts of CD11b + Ly6C + 248 monocytes and CD11b + Ly6G + granulocytes (neutrophils) in HK treated mice (Fig. S5) .
249
Blood samples taken twelve hours after the HK injections with S. aureus or S. pyogenes showed signifi-250 cant reduction of leukocytes, confirming the effect of the treatments. However, S. aureus HK treatment also 251 reduced significantly monocytes, neutrophils, and platelets, in contrast to HK S. pyogenes treatment, verifying 252 that HK treatment with S. aureus is more effective than with S. pyogenes. Change in lymphocyte numbers was 253 insignificant after both treatments (data not shown).
254
For the experiments regarding antigen-specificity, S. pyogenes was chosen because together with S. aureus 255 they are the two most common gram-positive cocci of medical significance 39 . Interestingly, HK administration 256 of the S. pyogenes antigen, still cured half of the infected hosts. This could possibly happen as a result of trained 257 immunity, a de facto immune memory of the innate immune system, which is believed to empower a stronger 258 immune response upon a subsequent inflammatory stimulus 40 . To clarify this possibility, future work could be 259 to experiment with infected mice deprived of T cells (e.g. Rag, SCID, or nude mice) and observe their response 260 to our HK treatment protocols. The 50% sterilizing immunity in HK S. pyogenes treated mice (Fig. 3C ) may 261 also imply that a non-antigen specific HK perturbation should be combined with other perturbation strategies 262 (antigen specific or not) to be completely effective. Nevertheless, our in silico results suggest that a higher HK S.
263
pyogenes dose alone could have eliminated more MDSCs and hence could have reduced T cell suppression to a 264 higher extent. The freed T cells would have then be able to exert their aggressive effect on bacteria and possibly 265 also completely resolve the infection (Fig. S4) . Future experiments could be conducted to test these hypotheses.
266
The hallmark of our model is that it can predict how each perturbation strategy may provide the sufficient before proceeding to the numerical analysis.
272
Applying treatment with HK bacteria has not only enhanced T cell activation, as we originally aimed and 273 expected, but has also led to reduction of MDSCs and hence their inhibitory effect on T cells. Consequently, in 274 the separatrix in Fig. 2A , the infected mouse condition did not improve by an upwardly vertical movement, as 275 expected, but rather a diagonal left movement. This indicates that in bacterial infections autovaccination targets 276 indirectly MDSCs, a fact that stayed until now unknown. It is hence likely that treated mice were cured some 277 days before the scheduled sampling day. Future work could be to add a differential equation describing the 278 population of MDSCs in time.
279
Additionally, we investigated why treatments using killed bacteria have not provided cure in the past. Heat-280 or formalin-killed bacteria treatments are narrowly established in medicine because there is no specific proto-281 col stating the exact dose, number of injections and time between injections that would guarantee sterilizing 282 immunity. Our analysis suggested that numerous injections with increasing dose or fixed dose of killed cells 283 cannot render cure (Fig. 4) if the dose given does not exceed the threshold of effective dose that is required for 284 clearance. Interestingly our study demonstrated that sterilizing immunity can be achieved with just one or only 285 a few injections with high dose of HK bacteria (Fig. S7 ). Our interpretation is that HK treatments lead to cure 286 when they succeed in initiating a strong immune response. Multiple injections that contain a low HK dose do 287 not accomplish a sufficient immune reactivation that can resolve the infection, even if they are administered over 288 a long period of time.
289
Our proposed HK injection protocol verified experimentally that sterilizing immunity can be achieved by 290 only one injection. However, according to our analysis more injections with a lesser HK dose could still result 291 in sterilizing immunity, if the intervals between the injections are short (Figs. S6-S7 ). Furthermore, the shorter 292 the interval between treatments, the quicker the cure is achieved (data not shown).
293
The model also suggests that the sequence of the injection dates plays a major role in the outcome of the 294 infection. For injections containing equal HK doses administered in different days post-infection, the infection 295 is resolved in one case but remains unresolved in the other case (Fig. S8) The mathematical model applies to the chronic, non-acute infections caused by S. aureus. It comprises of currently known interactions between bacteria B(t), T cells T(t) and MDSCs Σ.
The ODE system readṡ
Immunosuppression driven by MDSCs can be achieved in two ways. On the one hand, the bacterium can activate 310 the MDSCs, which are resident in the site of infection. This is expressed with the term c T B(t)T (t) and implies the 311 local immunosuppression by MDSCs. On the other hand, the activation and expansion of MDSCs can take place 312 systemically, as a generic protective mechanism of the organism against long-lasting strong inflammation or as 313 a mechanism of the bacteria for persistence. This is represented with the term Σ · T (t), since MDSC-mediated CD4 + T cells 31 . In the following the term T cells will refer to the effector CD4 + T cells unless otherwise stated.
323
The mathematical model was implemented and simulated in MATLAB, see www.mathworks.com.
324
Fitting curves and standard deviation of parameters 325 The unknown parameters in the model were estimated in three steps. First, the carrying capacity of bacteria κ was estimated based on the data reported in Fig. 5A 31 , where S. aureus infected Rag-deficient mice showed nearly constant level of S. aureus in kidney from day 7 till day 56. The mean of these data points was taken as the carrying capacity. Secondly, the growth rate of bacteria was estimated by solving the logistic growth equation
where κ is the carrying capacity, P 0 is the initial inoculation number of bacteria and P is the bacterial CFU at 326 time t. Our previous experimental data showed that the bacterial loads in Rag-deficient mice reached 75% of the 327 carrying capacity on day 2 and fluctuated afterwards, after intravenous inoculation with 7×10 7 CFU S. aureus.
328
Assuming that bacterial load reached 75% of the carrying capacity by day 1 or day 2, we determined the high 329 and low boundary of r b to be 0.636 and 0.318, respectively. The average of the low and high boundary was 330 taken as the bacterial growth rate in the next step. Finally, the rest of the unknown parameters were estimated 331 by fitting the data reported in Fig. 8B 31 , where the absolute number of CD4+ T cells in peripheral lymph nodes was monitored. The fitting process used a Markov Chain Monte Carlo version of Differential Evolution algorithm 44 . Parameter c T appeared much smaller than other parameters in the initial investigation. We tested, in 334 a second study, the possibility of fitting the same data with c T = 0. The fit quality remained the same, therefore 335 we concluded that c T is zero. Simulating the perturbation treatment 339
To simulate the perturbation strategy, we incorporated for a perturbation window (e.g. 12 hours) another term and k b = 0.001509 [days −1 ] as estimated during the fitting process (Table 1) . However, since the new term 342 describes the addition of bacteria, despite them being inactivated, one would suggest that the term should be 343 incorporated into the bacterial ODE. One would also argue that addition of heat-killed bacteria would initiate an 344 acute inflammation, and hence result in reduction of MDSCs, which are associated with chronic infections. To 345 eliminate all doubts about the model's predictions and robustness, we integrated the term in all three suggested 346 locations in ODEs as shown below.
347
If heat-killed bacteria treatment is integrated in the T cell ODĖ
then cure is expected by day 34.5.
349
If heat-killed bacteria treatment is integrated in the bacterial ODĖ
then cure is expected by day 29.6.
351
If heat-killed bacteria treatment diminishes the MDSC effecṫ
then cure is expected by day 14.15.
353
All of them revealed eradication of bacterial cells by day 37 post-infection, the experimental measurent day.
354
The perturbation strategy of the k b increase, as shown in this study, was simulated utilizing the equations (3).
355
Experimental protocols Figure S1 : T cells and MDSCs exhibit an inverse proportional behaviour. Correlation between T cells and MDSC-mediated suppression is shown. The correlation was plotted using the analytical solutions of the T cell differential equation in steady state (Supplementary, Eq. S10) for increasing amounts of parameter Σ, representing the MDSCs. (Table 1) for a perturbation window of 2 or 6 days. (Table 1) . Non-antigen specific stimulation means that streptococcal heat-killed bacteria stimulate the immune system with a lower rate than staphylococcal HK cells, e.g. k b 2 = k b /2 or k b 3 = k b /3. Simulation of treatment was done by adding the term k b · B d in the T cell ODE for a perturbation window of half day (Methods), where k b the immunostimulatory parameter and B d different doses of HK cells. The estimated day of clearance was defined the first time point when bacterial numbers < 0.000001. Figure S6 : Correlation between HK doses, number of HK injections and intervals between injections. In silico predictions for cure plotted for HK doses ranging from 10 6 to 10 7 , number of injections between 1 to 20, and intervals between injections from 0 days to 7 days, or 2 weeks. For each injection day, the treatment was incorporated in the T cell ODE as k b · B d , where k b the parameter defined in Table 1 and B d the administered dose (Methods). (A) Reduction of both the cure regime (blue) and possibility of cure with increasing intervals between HK injections. (B) Minimum HK dose needed for cure according to the number of HK injections and intervals between injections. For HK doses in the range [10 6 , 10 7 ] cure can be achieved only if the injections have intervals of 1, 2 or 3 days. (C) Three dimensional plot shows the "Cure" and "No cure" regions and their interconnection between HK dose, HK injections and intervals between injections. Figure S9 : Plots for fitted model parameters r t , c T , k b , c b , and Σ using a Markov Chain Monte Carlo version of Differential Evolution algorithm (Methods). Parameter values and confidence intervals are shown in Table 1 .
Infiltration of monocytes
Scaling the model 542
With the following change of variables we non-dimensionalize the ODE model (2).
Let's say that the coefficients of ξ , ξ 2 and ξ ψ are equal 1. Then
Therefore the new, non-dimensionalized equation for bacteria is
For the equationṪ (t) we have the non-dimensionalized calculations:
Substitution of the t 0 , β 0 and c 0 (found in Equation (S2)) gives the scaled equation for T: Consequently the system has four equilibrium points in total:
561
• (ξ 1 , ψ 1 ) = (0, 0) 562 • (ξ 2 , ψ 2 ) = (0, δ α )
563
• (ξ 3,4 , ψ 3,4 ) = (1 − ψ 3,4 , ψ 3,4 ) where ψ 3,4 is shown in equation (S10).
564
Existence of ψ 3,4 565 Equilibrium points ψ 3,4 exist only when ∆ = (β +γ +δ ) 2 −4β (α +γ) ≥ 0, i.e. only when ψ 3,4 have no imaginary 566 part.
567
Equivalently (β + γ + δ ) 2 − 4β (α + γ) ≥ 0
According to the sign of the term (α − δ ) in condition (S11), we investigate when the equilibrium points 570 ψ 3,4 exist.
571
• If α − δ ≤ 0 =⇒ δ ≥ a then the equilibria ψ 3,4 exist.
572
• If 0 < δ < α then we deformulate ∆ as follows:
574 a) If −β + γ + δ ≥ 0 then for existence of ψ 3,4 we require −β + γ + δ − 2 β √ α − δ ≥ 0. Then: 
Note: The solution β ≥ √ α − δ − √ α + γ is trivially exempt.
579
In summary, equilibrium points ψ 3,4 exist for the range of δ and √ k b shown in Fig. S10 .
580
Region of nonexistence Figure S10 : Existence of equilibrium points ψ 3,4 .
Local stability analysis of equilibrium points
The sign of the determinant depends on the term 1 − δ α . When δ > α, the equilibrium point is saddle.
584
This becomes unstable when δ < α. Next, we evaluate the Jacobian matrix in the equilibrium points (ξ 3,4 , ψ 3,4 ), 
We obtain the trace of the Jacobian matrix to determine the type of stability of equilibrium points (ξ 3,4 , ψ 3,4 ), tr(J) = −1 − δ + γ(−1 + ψ) + ψ + 2αψ = (1 + 2α + γ)ψ − (1 + γ + δ )
We first need to find some critical values for ψ:
587
• If |J(1 − ψ, ψ)| = 0, then 588 ψ * 1 = β + γ + δ 2(α + γ) (S21) 589 We know that the term (1 − ψ) equals ξ , which represents the bacteria, and hence ξ = 1 − ψ ≥ 0. From the critical points found in equations (S21) and (S22), the stability of the equilibrium points (ξ 3,4 , ψ 3,4 ) = Assuming Σ * = r t r b c b and substituting α, β , and δ from equations (S7),
Since ξ and ψ are normalized, ξ , ψ ≥ 0 and therefore 0 ≤ ψ * 1 , ψ 
